Literature DB >> 10909042

Gastrointestinal abnormalities and involvement in systemic mastocytosis.

R T Jensen1.   

Abstract

Recent studies have shown that involvement of the gastrointestinal tract is much more frequent than originally reported in patients with systemic mastocytosis. Seventy percent to 80% of patients with systemic mastocytosis are found to have gastrointestinal symptoms when a careful history is taken, and abnormalities in the gastrointestinal tract are frequently detected by endoscopic studies, functional studies of absorption, and barium studies. Because of the rarity of the disease, there are few prospective studies of gastrointestinal involvement, so the actual frequency of upper and lower gastrointestinal lesions is unknown. Furthermore, there have been no studies correlating endoscopic abnormalities of the lower gastrointestinal tract with the presence or absence of diarrhea, which is a frequent symptom (mean, 43% [range 14%-100%]). A review of gastric acid studies reveals that a proportion of patients develop gastric acid hypersecretion because of the hyperhistaminemia, which can result in ulcer disease that in turn can cause dyspeptic pain, small intestinal mucosal damage, and malabsorption. In some patients gastric acid hypersecretion in the range seen in Zollinger-Ellison syndrome can develop. A number of studies suggest that the prevalence of peptic ulcer disease has been underestimated in these patients and is certainly higher than the general population. The exact physiologic basis for the diarrhea or nondyspeptic abdominal pain remains largely unknown in these patients. Whereas some studies suggest small intestinal mucosal abnormalities are responsible for most cases of malabsorption not associated with gastric acid hypersecretion, this supposition also remains unproven. Hepatomegaly, portal hypertension, splenomegaly, and ascites occur frequently in patients with systemic mastocytosis, especially those with category II through IV disease. Whereas the histology of the liver and spleen and alterations in hepatic function studies have been well studied, the pathogenesis of each of these abnormalities has not been well studied, and almost all the information comes from a few well-studied case reports.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10909042     DOI: 10.1016/s0889-8588(05)70298-7

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  22 in total

1.  Systemic mastocytosis presenting with gastrointestinal, bone and skin involvement.

Authors:  Maria Rosignuolo; Marta Muscianese; Guglielmo Pranteda
Journal:  J Ultrasound       Date:  2014-04-08

Review 2.  Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.

Authors:  Tetsuhide Ito; Guillaume Cadiot; Robert T Jensen
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

3.  Systemic mastocytosis: A rare cause of non-cirrhotic portal hypertension.

Authors:  Cláudio Martins; Cristina Teixeira; Suzane Ribeiro; Daniel Trabulo; Cláudia Cardoso; João Mangualde; Ricardo Freire; Élia Gamito; Ana Luísa Alves; Isabelle Cremers; Cecília Alves; Anabela Neves; Ana Paula Oliveira
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

4.  A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.

Authors:  Leona A Doyle; Golrokh J Sepehr; Matthew J Hamilton; Cem Akin; Mariana C Castells; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

5.  An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).

Authors:  H-P Horny; K Sotlar; F Stellmacher; P Valent; J Grabbe
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

6.  Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

Authors:  Mar Guilarte; Javier Santos; Inés de Torres; Carmen Alonso; María Vicario; Laura Ramos; Cristina Martínez; Francesc Casellas; Esteban Saperas; Juan Ramón Malagelada
Journal:  Gut       Date:  2006-09-27       Impact factor: 23.059

Review 7.  Gastric acid hypersecretory states: recent insights and advances.

Authors:  Nauramy Osefo; Tetsuhide Ito; Robert T Jensen
Journal:  Curr Gastroenterol Rep       Date:  2009-12

Review 8.  Gastrointestinal manifestations of systemic mastocytosis.

Authors:  Jason K Lee; Scott J Whittaker; Robert A Enns; Peter Zetler
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

Review 9.  Physiological and pathophysiological functions of intestinal mast cells.

Authors:  Stephan C Bischoff
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 10.  Mastocytosis.

Authors:  Melody C Carter; Dean D Metcalfe; Hirsh D Komarow
Journal:  Immunol Allergy Clin North Am       Date:  2013-10-07       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.